1. California Institute of Technology (40 from 4,547 patents)

2. Indi Molecular, Inc. (8 from 13 patents)

3. University of California (7 from 15,458 patents)

4. Siemens Medical Solutions Usa, Inc. (4 from 2,075 patents)

5. Hewlett-packard Development Company, L.p. (3 from 27,394 patents)

6. Hewlett-packard Company (3 from 9,638 patents)

7. Gwangju Institute of Science and Technology (1 from 471 patents)

8. Fluidigm Corporation (1 from 159 patents)

9. Hewlett-packard Corporation (1 from 156 patents)

10. Cal. Inst. Tech. (1 from 1 patent)

1. 12258613 - Pairing antigen specificity of a T cell with T cell receptor sequences

2. 11723944 - Botulinum neurotoxin-specific capture agents, compositions, and methods of using and making

3. 11719705 - IL-17F and IL-17A-specific capture agents, compositions, and methods of using and making

4. 11384327 - Microfluidic devices and methods for purifying rare antigen-specific T cell populations

5. 11371994 - Phosphorylated Akt-specific capture agents, compositions, and methods of using and making

6. 11365219 - Cyclic peptides as protein targeting agents

7. 11365220 - Methods of making anti-GP41 antibody-specific capture agents

8. 11353448 - Methods and compositions for quantifying metabolites and proteins from single cells

9. 11168115 - Cyclic peptides as protein targeting agents

10. 11007245 - Botulinum neurotoxin-specific capture agents, compositions, and methods of using and making

11. 10975123 - Mutant Akt-specific capture agents, compositions, and methods of using and making

12. 10928389 - Arrays, substrates, devices, methods and systems for detecting target molecules

13. 10913774 - Cyclic peptide binder against oncogenic K-Ras

14. 10597425 - Anti-GP41 antibody-specific capture agents, compositions, and methods of using and making

15. 10598671 - IL-17F-specific capture agents, compositions, and methods of using and making